STOCK TITAN

CompuMed Press Release re Reverse Stock Split

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

CompuMed, Inc. (OTC PINK:CMPD) announced a 25:1 reverse stock split approved by stockholders in March 2022. The company is finalizing documents with FINRA and its transfer agent, ComputerShare, to implement this split, expected by mid-May 2022. CompuMed specializes in diagnostic telemedicine, offering services like telecardiology and teleradiology to provide affordable, real-time access to U.S. Board-Certified specialists. The company has been operational for over 26 years, servicing 1,000+ clinical settings worldwide.

Positive
  • Approval of a 25:1 reverse stock split aims to improve share price and attract more institutional investors.
  • CompuMed's telemedicine services enhance access to healthcare, potentially increasing demand and revenue.
Negative
  • The reverse stock split could signal previous share price struggles, indicating potential investor concerns.
  • Risks associated with market volatility and competition could impact future financial performance.

LOS ANGELES, CA / ACCESSWIRE / April 20, 2022 / CompuMed, Inc. (OTC PINK:CMPD), a leader in providing diagnostic telemedicine, announced in March 2022 the approval by its stockholders of a 25:1 reverse stock split.

As previously disclosed, the Company is in the process of submitting the appropriate documents to FINRA and its transfer agent, ComputerShare, to effect the reverse stock split as quickly as possible, with an anticipated effective date in mid - May 2022; the Company will provide updates as the effective date becomes closer.

Inquiries regarding this can be sent to investorrelations@compumedinc.com

About CompuMed, Inc.

CompuMed, Inc. (OTC PINK:CMPD) Diagnostic Telemedicine services provide patients with the highest level of clinical care at reduced costs. Its telecardiology and teleradiology offerings provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities anywhere in the world. The company has been in business over 26 years and services over 1,000 clinical settings. CompuMed is headquartered in Los Angeles, CA. Visit CompuMed at www.compumedinc.com.

Forward-Looking Statements

Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all passages containing words such as "will," "aims," "anticipates," "becoming," "believes," "continue," "estimates," "expects," "future," "intends," "plans," "predicts," "projects," "targets," or "upcoming." Forward-looking statements also include any other passages that are primarily relevant to expected future events or that can only be evaluated by events that will occur in the future. Forward-looking statements are based on the opinions and estimates of management at the time the statements are made and are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated or implied in the forward-looking statements. Factors that could cause actual results to vary from current expectations and forward-looking statements contained in this press release include, but are not limited to: the timing and volume of business activity from our clients and our ability to continue to provide products and services to such clients; the loss of, or reduction of business from, material clients; our liquidity and cash position; changes in technology; our ability to protect the Company's net operating losses and tax benefits; volatility and changes in our stock price, corporate or other market conditions; changes in government regulations or economic conditions; the impact of increased competition and pricing; capacity and supply chain constraints or difficulties; and other factors contained in the Company's filings posted on the OTC Markets website. All such forward-looking statements are expressly qualified by these cautionary statements. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect events, conditions or circumstances on which any such statement is based after the date hereof, except as required by law.

SOURCE: CompuMed, Inc.



View source version on accesswire.com:
https://www.accesswire.com/698263/CompuMed-Press-Release-re-Reverse-Stock-Split

FAQ

What is the reverse stock split for CMPD?

The approved reverse stock split for CMPD is 25:1, aimed at improving share value.

When will the reverse stock split take effect?

The reverse stock split is anticipated to become effective in mid-May 2022.

What services does CompuMed offer?

CompuMed provides diagnostic telemedicine services including telecardiology and teleradiology.

How long has CompuMed been in operation?

CompuMed has been in business for over 26 years.

Where is CompuMed headquartered?

CompuMed is headquartered in Los Angeles, CA.

COMPUMED INC

OTC:CMPD

CMPD Rankings

CMPD Latest News

CMPD Stock Data

4.48M
42.05M
Health Information Services
Healthcare
Link
United States of America
Los Angeles